| ［1］ |
Montagnon CM, Tolkachjov SN, Murrell DF, et al. Intraepithelial autoimmune blistering dermatoses: clinical features and diagnosis［J］. J Am Acad Dermatol, 2021,84（6）:1507⁃1519. DOI: 10. 1016/j.jaad.2020.11.075.
|
| ［2］ |
Kridin K, Zelber⁃Sagi S, Comaneshter D, et al. Coexistent solid malignancies in pemphigus: a population⁃based study［J］. JAMA Dermatol, 2018,154（4）:435⁃440. DOI: 10.1001/jamadermatol. 2017.6334.
|
| ［3］ |
Warshavsky K, Zeeli T, Mekiten O, et al. Coexistence of malignancies in pemphigus vulgaris［J］. Immunol Res, 2023,71（5）:743⁃748. DOI: 10.1007/s12026⁃023⁃09388⁃y.
|
| ［4］ |
Maglie R, Montefusco F, Senatore S, et al. Localized pemphigus exacerbation associated with underlying breast cancer［J］. JAAD Case Rep, 2020,6（12）:1268⁃1270. DOI: 10.1016/j.jdcr.2020. 10.018.
|
| ［5］ |
Corrà A, Cammelli F, Quintarelli L, et al. Case report: management of malignancy⁃exacerbated pemphigus vulgaris during COVID⁃19 pandemic［J］. Front Med （Lausanne）, 2021,8:708284. DOI: 10.3389/fmed.2021.708284.
|
| ［6］ |
Streifel AM, Wessman LL, Schultz BJ, et al. Refractory mucositis associated with underlying follicular dendritic cell sarcoma of the thymus: paraneoplastic pemphigus versus malignancy⁃exacerbated pemphigus vulgaris［J］. JAAD Case Rep, 2019,5（11）:933⁃936. DOI: 10.1016/j.jdcr.2019.09.009.
|
